Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 116

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300

Gardete, Susana, Kim, Choonkeun, Hartmann, Boris M., Mwangi, Michael, Roux, Christelle M., Dunman, Paul M., Chambers, Henry F., Tomasz, Alexander·2012·PLoS Pathogens

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1002505

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 66

  1. SK Pillai, 2009, Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus., Clin Infect Dis, 49, 1169, 10.1086/605636 · DOI
  2. K Hiramatsu, 1997, Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin., Lancet, 350, 1670, 10.1016/S0140-6736(97)07324-8 · DOI · Paper page
  3. TL Smith, 1999, Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-intermediate Staphylococcus aureus Working Group., N Engl J Med, 340, 493, 10.1056/NEJM199902183400701 · DOI · Paper page
  4. K Sieradzki, 1999, The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection., N Engl J Med, 340, 517, 10.1056/NEJM199902183400704 · DOI · Paper page
  5. K Sieradzki, 2003, Evolution of a vancomycin-intermediate Staphylococcus aureus strain in vivo: Multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for chemotherapy., J Clin Microbiol, 41, 1687, 10.1128/JCM.41.4.1687-1693.2003 · DOI
  6. MM Mwangi, 2007, Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing., Proc Natl Acad Sci U S A, 104, 9451, 10.1073/pnas.0609839104 · DOI · Paper page
  7. K Sieradzki, 2003, Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus., J Bacteriol, 185, 7103, 10.1128/JB.185.24.7103-7110.2003 · DOI · Paper page
  8. BP Howden, 2006, Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia., Antimicrob Agents Chemother, 50, 3039, 10.1128/AAC.00422-06 · DOI · Paper page
  9. S Gardete, 2008, Identification of the first vancomycin intermediate-resistant Staphylococcus aureus (VISA) isolate from a hospital in Portugal., Microb Drug Resist, 14, 1, 10.1089/mdr.2008.0816 · DOI
  10. CJ Graber, 2007, Intermediate vancomycin susceptibility in a community-associated MRSA clone., Emerg Infect Dis, 13, 491, 10.3201/eid1303.060960 · DOI
  11. JC Hageman, 2008, Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus., Diagn Microbiol Infect Dis, 62, 440, 10.1016/j.diagmicrobio.2008.08.005 · DOI
  12. BL De Jonge, 1992, Peptidoglycan composition of a highly methicillin-resistant Staphylococcus aureus strain. The role of penicillin binding protein 2A., J Biol Chem, 267, 11248, 10.1016/S0021-9258(19)49903-1 · DOI · Paper page
  13. S Dubrac, 2008, A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway., Mol Microbiol, 70, 1307, 10.1111/j.1365-2958.2008.06483.x · DOI · Paper page
  14. S Dubrac, 2007, New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus., J Bacteriol, 189, 8257, 10.1128/JB.00645-07 · DOI · Paper page
  15. M Meehl, 2007, Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus., Antimicrob Agents Chemother, 51, 2679, 10.1128/AAC.00209-07 · DOI · Paper page
  16. Y Kato, 2010, Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR., J Antimicrob Chemother, 65, 37, 10.1093/jac/dkp394 · DOI
  17. JM Mei, 1997, Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis., Mol Microbiol, 26, 399, 10.1046/j.1365-2958.1997.5911966.x · DOI · Paper page
  18. LF Abu-Qatouseh, 2010, Identification of differentially expressed small non-protein-coding RNAs in Staphylococcus aureus displaying both the normal and the small-colony variant phenotype., J Mol Med, 88, 565, 10.1007/s00109-010-0597-2 · DOI
  19. M Kuroda, 2000, Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method., Biochem Biophys Res Commun, 269, 485, 10.1006/bbrc.2000.2277 · DOI · Paper page
  20. M Kuroda, 2003, Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus., Mol Microbiol, 49, 807, 10.1046/j.1365-2958.2003.03599.x · DOI · Paper page
  21. S Boyle-Vavra, 2003, Transcriptional induction of the penicillin-binding protein 2 gene in Staphylococcus aureus by cell wall-active antibiotics oxacillin and vancomycin., Antimicrob Agents Chemother, 47, 1028, 10.1128/AAC.47.3.1028-1036.2003 · doi:10.1128/aac.47.3.1028-1036.2003
  22. S Jordan, 2006, Regulation of LiaRS-dependent gene expression in Bacillus subtilis: identification of inhibitor proteins, regulator binding sites, and target genes of a conserved cell envelope stress-sensing two-component system., J Bacteriol, 188, 5153, 10.1128/JB.00310-06 · DOI · Paper page
  23. P Suntharalingam, 2009, The LiaFSR system regulates the cell envelope stress response in Streptococcus mutans., J Bacteriol, 191, 2973, 10.1128/JB.01563-08 · DOI
  24. F Fritsch, 2011, The cell envelope stress response mediated by the LiaFSRLm three-component system of Listeria monocytogenes is controlled via the phosphatase activity of the bifunctional histidine kinase LiaSLm., Microbiology, 157, 373, 10.1099/mic.0.044776-0 · DOI
  25. N McCallum, 2011, Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus., Antimicrob Agents Chemother, 55, 1391, 10.1128/AAC.01213-10 · DOI
  26. H Szurmant, 2007, YycH and YycI interact to regulate the essential YycFG two-component system in Bacillus subtilis., J Bacteriol, 189, 3280, 10.1128/JB.01936-06 · DOI
  27. A Jansen, 2007, Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus., Int J Med Microbiol, 297, 205, 10.1016/j.ijmm.2007.02.002 · DOI · Paper page
  28. A Reipert, 2003, Morphological and genetic differences in two isogenic Staphylococcus aureus strains with decreased susceptibilities to vancomycin., Antimicrob Agents Chemother, 47, 568, 10.1128/AAC.47.2.568-576.2003 · DOI
  29. L Cui, 2009, Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus., Antimicrob Agents Chemother, 53, 1231, 10.1128/AAC.01173-08 · DOI
  30. BP Howden, 2008, Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus., Antimicrob Agents Chemother, 52, 3755, 10.1128/AAC.01613-07 · DOI
  31. H Tjalsma, 1999, The potential active site of the lipoprotein-specific (type II) signal peptidase of Bacillus subtilis., J Biol Chem, 274, 28191, 10.1074/jbc.274.40.28191 · DOI
  32. S Utaida, 2003, Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon., Microbiology, 149, 2719, 10.1099/mic.0.26426-0 · DOI · Paper page
  33. S Gardete, 2006, Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus., Antimicrob Agents Chemother, 50, 3424, 10.1128/AAC.00356-06 · DOI · Paper page
  34. JJ Iandolo, 2002, Comparative analysis of the genomes of the temperate bacteriophages phi 11, phi 12 and phi 13 of Staphylococcus aureus 8325., Gene, 289, 109, 10.1016/S0378-1119(02)00481-X · DOI · Paper page
  35. T Ohta, 2004, Nucleotide substitutions in Staphylococcus aureus strains, Mu50, Mu3, and N315., DNA Res, 11, 51, 10.1093/dnares/11.1.51 · DOI
  36. L Cui, 2005, DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus., Antimicrob Agents Chemother, 49, 3404, 10.1128/AAC.49.8.3404-3413.2005 · DOI
  37. BP Howden, 2008, Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia., BMC Microbiol, 8, 39, 10.1186/1471-2180-8-39 · DOI
  38. F McAleese, 2006, Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate- S. aureus-type resistance to vancomycin., J Bacteriol, 188, 1120, 10.1128/JB.188.3.1120-1133.2006 · DOI · Paper page
  39. E Mongodin, 2003, Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin., J Bacteriol, 185, 4638, 10.1128/JB.185.15.4638-4643.2003 · DOI
  40. A Scherl, 2006, Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers., BMC Genomics, 7, 296, 10.1186/1471-2164-7-296 · DOI
  41. B Loffler, 2010, Staphylococcus aureus panton-valentine leukocidin is a very potent cytotoxic factor for human neutrophils., PLoS Pathog, 6, e1000715, 10.1371/journal.ppat.1000715 · DOI · Paper page
  42. JA Loughman, 2009, Virulence gene expression in human community-acquired Staphylococcus aureus infection., J Infect Dis, 199, 294, 10.1086/595982 · DOI
  43. CP Montgomery, 2008, Comparison of virulence in community-associated methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a rat model of pneumonia., J Infect Dis, 198, 561, 10.1086/590157 · DOI · Paper page
  44. AE Villaruz, 2009, A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation., J Infect Dis, 200, 724, 10.1086/604728 · DOI
  45. PM Dunman, 2001, Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci., J Bacteriol, 183, 7341, 10.1128/JB.183.24.7341-7353.2001 · DOI · Paper page
  46. B Said-Salim, 2003, Global regulation of Staphylococcus aureus genes by Rot., J Bacteriol, 185, 610, 10.1128/JB.185.2.610-619.2003 · DOI · Paper page
  47. K Tegmark, 2000, Identification and characterization of SarH1, a new global regulator of virulence gene expression in Staphylococcus aureus., Mol Microbiol, 37, 398, 10.1046/j.1365-2958.2000.02003.x · DOI · Paper page
  48. AA Pragman, 2007, Repression of Staphylococcus aureus SrrAB using inducible antisense srrA alters growth and virulence factor transcript levels., Biochemistry, 46, 314, 10.1021/bi0603266 · DOI
  49. AY Peleg, 2009, Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection., J Infect Dis, 199, 532, 10.1086/596511 · DOI · Paper page
  50. A Lalueza, 2010, Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?, J Infect Dis, 201, 311, 10.1086/649572 · DOI
  51. KC Horne, 2009, Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA., Antimicrob Agents Chemother, 53, 3447, 10.1128/AAC.01365-08 · DOI
  52. J Price, 2009, Paradoxical relationship between the clinical outcome of Staphylococcus aureus bacteremia and the minimum inhibitory concentration of vancomycin., Clin Infect Dis, 48, 997, 10.1086/597359 · DOI
  53. DR Cameron, 2011, The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes., Clin Infect Dis, 53, 576, 10.1093/cid/cir473 · DOI
  54. PA Majcherczyk, 2008, Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis., Microb Pathog, 45, 408, 10.1016/j.micpath.2008.09.003 · DOI
  55. S Wu, 1996, A phosphoglucomutase-like gene essential for the optimal expression of methicillin resistance in Staphylococcus aureus: molecular cloning and DNA sequencing., Microb Drug Resist, 2, 277, 10.1089/mdr.1996.2.277 · DOI
  56. BL De Jonge, 1991, Suppression of autolysis and cell wall turnover in heterogeneous Tn 551 mutants of a methicillin-resistant Staphylococcus aureus strain., J Bacteriol, 173, 1105, 10.1128/jb.173.3.1105-1110.1991 · doi:10.1128/jb.173.3.1105-1110.1991
  57. EJ Lowbury, 1964, Neomycin-Resistant Staphylococcus aureus In A Burns Unit., J Hyg (Lond), 62, 221, 10.1017/S0022172400039942 · DOI
  58. A Tomasz, 1991, Stable classes of phenotypic expression in methicillin-resistant clinical isolates of staphylococci., Antimicrob Agents Chemother, 35, 124, 10.1128/AAC.35.1.124 · DOI · Paper page
  59. DA Benson, 2010, GenBank., Nucleic Acids Res, 38, D46, 10.1093/nar/gkp1024 · DOI · Paper page
  60. SK Highlander, 2007, Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus., BMC Microbiol, 7, 99, 10.1186/1471-2180-7-99 · DOI · Paper page
  61. KE Beenken, 2004, Global gene expression in Staphylococcus aureus biofilms., J Bacteriol, 186, 4665, 10.1128/JB.186.14.4665-4684.2004 · DOI · Paper page
  62. ZJ Wu, 2004, A model-based background adjustment for oligonucleotide expression arrays., J Am Stat Assoc, 99, 909, 10.1198/016214504000000683 · DOI · Paper page
  63. G Kraemer, 1990, High-frequency transformation of Staphylococcus aureus by electroporation., Curr Microbiol, 21, 373, 10.1007/BF02199440 · DOI · Paper page
  64. Y Katayama, 2003, Jumping the barrier to beta-lactam resistance in Staphylococcus aureus., J Bacteriol, 185, 5465, 10.1128/JB.185.18.5465-5472.2003 · DOI
  65. M Chung, 2008, Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole., Antimicrob Agents Chemother, 52, 2709, 10.1128/AAC.00266-08 · DOI
  66. XJ Zhao, 1992, Nucleotide sequence of the Staphylococcus aureus signal peptidase II (lsp) gene., FEBS Lett, 299, 80, 10.1016/0014-5793(92)80105-P · DOI

Cited by

See all 116

Metadata

Authors
Gardete, S., Kim, C., Hartmann, B. M., Mwangi, M., Roux, C. M., Dunman, P. M., Chambers, H. F., & Tomasz, A.
Venue
PLoS Pathogens
Published
2012-02-02
Volume
8
Issue
2
Pages
e1002505
ISSN
1553-7374
Cited by
116
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300. https://app.cochat.ai/papers/10.1371/journal.ppat.1002505
The paper
Gardete, S., Kim, C., Hartmann, B. M., Mwangi, M., Roux, C. M., Dunman, P. M., Chambers, H. F., & Tomasz, A. (2012). Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300. PLoS Pathogens. https://doi.org/10.1371/journal.ppat.1002505

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.